4SC AG Logo

4SC AG

Biopharmaceutical company with no products under development or operational business.

VSC | F

Overview

Corporate Details

ISIN(s):
DE000A3E5C40
LEI:
391200QOKN7LGVP0RQ86
Country:
Germany
Address:
Fraunhoferstr. 22, 82152 Planegg

Description

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2015-07-10 13:00 German HTML 4.1 KB
2015-07-07 22:12
4SC AG secures EUR 29 million from capital increase to finance planned clinical…
English HTML 10.3 KB
2015-07-02 22:14
4SC AG announces subscription price for new shares from current capital increase
English HTML 8.0 KB
2015-07-01 07:30
Press Release: 4SC strengthens patent protection for lead cancer compound resmi…
English HTML 9.9 KB
2015-06-26 07:30
Press Release: 4SC's partner Yakult Honsha enters with cancer compound resminos…
English HTML 15.6 KB
2015-06-22 13:40
4SC AG plans to issue new shares to finance the further development of its epig…
English HTML 12.5 KB
2015-06-17 15:15
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.07.2015 in P…
German HTML 41.4 KB
2015-06-03 23:23 German HTML 5.2 KB
2015-06-03 07:30
Press Release: 4SC presents final results from Phase I AEGIS trial as well as r…
English HTML 14.1 KB
2015-05-29 17:00
Release according to Article 26a of the WpHG [the German Securities Trading Act…
English HTML 1.5 KB
2015-05-07 07:30
Press Release: 4SC Announces Financial Results for the First Quarter of 2015
English HTML 22.3 KB
2015-05-07 00:00
Q1 Report 2015
English PDF 1.7 MB
2015-05-04 15:46
4SC to present at three upcoming investor conferences
English HTML 7.2 KB
2015-04-30 15:00
Announcement: 4SC AG to host conference call on 7 May 2015 to present first qua…
English HTML 7.5 KB
2015-04-30 10:17
Release according to Article 26a of the WpHG [the German Securities Trading Act…
English HTML 1.5 KB

Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 4SC AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 4SC AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900
ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.